Published in Pharmacol Ther on January 01, 1980
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun (1987) 6.47
Bacillus cereus and related species. Clin Microbiol Rev (1993) 5.37
Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun (1987) 4.92
Mechanism of membrane damage by streptolysin-O. Infect Immun (1985) 3.26
Nucleotide sequence of the type A staphylococcal enterotoxin gene. J Bacteriol (1988) 3.26
Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infect Immun (1987) 3.24
A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun (1999) 3.15
Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12. Infect Immun (1986) 2.90
Streptococcus adherence and colonization. Microbiol Mol Biol Rev (2009) 2.83
Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66
Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun (1984) 2.57
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Cloning and nucleotide sequence of the type E staphylococcal enterotoxin gene. J Bacteriol (1988) 2.41
Role of cholesterol in fusion of Semliki Forest virus with membranes. J Virol (1984) 2.32
Identification of the structural gene encoding the SH-activated hemolysin of Listeria monocytogenes: listeriolysin O is homologous to streptolysin O and pneumolysin. Infect Immun (1987) 2.16
PathogenFinder--distinguishing friend from foe using bacterial whole genome sequence data. PLoS One (2013) 1.97
Reduced virulence of a Listeria monocytogenes phospholipase-deficient mutant obtained by transposon insertion into the zinc metalloprotease gene. Infect Immun (1992) 1.79
Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun (1989) 1.64
The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect Immun (1989) 1.63
Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med (1989) 1.60
Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes. PLoS Pathog (2008) 1.53
Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O. Infect Immun (1991) 1.47
Nucleotide sequence of the type C3 staphylococcal enterotoxin gene suggests that intergenic recombination causes antigenic variation. J Bacteriol (1989) 1.46
Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun (2000) 1.45
Transport of influenza HA from the trans-Golgi network to the apical surface of MDCK cells permeabilized in their basolateral plasma membranes: energy dependence and involvement of GTP-binding proteins. J Cell Biol (1990) 1.45
Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun (1994) 1.44
Streptolysin S-like virulence factors: the continuing sagA. Nat Rev Microbiol (2011) 1.42
Reversible effects of nuclear membrane permeabilization on DNA replication: evidence for a positive licensing factor. J Cell Biol (1993) 1.40
The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family. J Bacteriol (1997) 1.40
Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J Biol Chem (2008) 1.38
Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun (2003) 1.34
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O. Infect Immun (1986) 1.28
Inability of toxin inhibitors to neutralize enhanced toxicity caused by bacteria adherent to tissue culture cells. Infect Immun (1990) 1.24
Phage influence on the synthesis of extracellular toxins in group A streptococci. Infect Immun (1982) 1.19
The incidence of scarlet fever. J Hyg (Lond) (1983) 1.15
Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect Immun (1986) 1.15
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case. Mol Cell Proteomics (2012) 1.13
Effects of oligopeptide permease in group a streptococcal infection. Infect Immun (2005) 1.11
The cytolytic toxin aerolysin must aggregate to disrupt erythrocytes, and aggregation is stimulated by human glycophorin. Infect Immun (1988) 1.10
A ring-shaped structure with a crown formed by streptolysin O on the erythrocyte membrane. J Bacteriol (1993) 1.08
Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun (2001) 1.06
Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect Immun (2003) 1.02
The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection. Infect Immun (2004) 1.01
Streptococcal growth and toxin production in vivo. Infect Immun (1983) 0.98
Immunologic cross-reactivity of type A streptococcal exotoxin (erythrogenic toxin) and staphylococcal enterotoxins B and C1. Infect Immun (1987) 0.98
Complement activation and attack on autologous cell membranes induced by streptolysin-O. Infect Immun (1985) 0.97
Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence. MBio (2013) 0.95
Autonomous expression of the slo gene of the bicistronic nga-slo operon of Streptococcus pyogenes. Infect Immun (2002) 0.93
Binding, oligomerization, and pore formation by streptolysin O in erythrocytes and fibroblast membranes: detection of nonlytic polymers. Infect Immun (1995) 0.93
Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans. Infect Immun (2002) 0.91
Heterogeneity of hemolytic efficiency and isoelectric point of streptolysin O. Infect Immun (1988) 0.87
Understanding fertilization through intracytoplasmic sperm injection (ICSI). Cell Calcium (2013) 0.87
Purification and characterization of a peptide essential for formation of streptolysin S by Streptococcus pyogenes. Infect Immun (1992) 0.86
Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum. Infect Immun (1992) 0.86
Purification and characterization of streptolysin O secreted by Streptococcus equisimilis (group C). Infect Immun (1993) 0.85
HIV protease inhibitors block streptolysin S production. ACS Chem Biol (2015) 0.83
A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius. J Clin Microbiol (2000) 0.82
Mammalian cells transfected with the listeriolysin gene exhibit enhanced proliferation and focus formation. Infect Immun (1994) 0.81
Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen. J Extracell Vesicles (2014) 0.80
YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function. Chem Rev (2017) 0.79
Role of neutrophil degranulation in streptococcal leukotoxicity. Infect Immun (1981) 0.79
Relationship between localization on cellular membranes and cytotoxicity of Vibrio vulnificus hemolysin. PLoS One (2011) 0.79
Differential virulence gene expression of group A Streptococcus serotype M3 in response to co-culture with Moraxella catarrhalis. PLoS One (2013) 0.79
Reduced set of virulence genes allows high accuracy prediction of bacterial pathogenicity in humans. PLoS One (2012) 0.79
Dynamin inhibition interferes with inflammasome activation and cytokine gene expression in Streptococcus pyogenes-infected human macrophages. Clin Exp Immunol (2014) 0.77
Streptococcal necrotizing fasciitis: development of an animal model to study its pathogenesis. Br J Exp Pathol (1988) 0.76
Inhibition of human breast cancer Matrigel invasion by Streptolysin O activation of the EGF receptor ErbB1. Cell Signal (2011) 0.75
Formation of ring-shaped structures on erythrocyte membranes after treatment with botulinolysin, a thiol-activated hemolysin from Clostridium botulinum. Infect Immun (1998) 0.75
Listeriolysin S Is a Streptolysin S-Like Virulence Factor That Targets Exclusively Prokaryotic Cells In Vivo. MBio (2017) 0.75
ASO titer or not? When to use streptococcal serology: a guide for clinicians. Eur J Clin Microbiol Infect Dis (2015) 0.75
Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun (1987) 6.47
Binding of cholesterol by sulfhydryl-activated cytolysins. Infect Immun (1980) 3.16
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Purification and characterization of an extracellular 29-kilodalton phospholipase C from Listeria monocytogenes. Infect Immun (1991) 2.41
Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide. Nature (1981) 1.85
Interaction of steptolysin O with sterols. Biochim Biophys Acta (1976) 1.84
Reduced virulence of a Listeria monocytogenes phospholipase-deficient mutant obtained by transposon insertion into the zinc metalloprotease gene. Infect Immun (1992) 1.79
[Action of streptolysin O on cell membranes. I. Fixation of erythrocyte membrane]. Ann Inst Pasteur (Paris) (1968) 1.63
Production of thiol-dependent haemolysins by Listeria monocytogenes and related species. J Gen Microbiol (1989) 1.55
T cell recognition of listeriolysin O is induced during infection with Listeria monocytogenes. J Immunol (1987) 1.53
Selective purification by thiol-disulfide interchange chromatography of alveolysin, a sulfhydryl-activated toxin of Bacillus alvei. Toxin properties and interaction with cholesterol and liposomes. J Biol Chem (1983) 1.49
[Action of streptolysin O on cellular membranes. II.--Kinetics of erythrocyte lysis]. Ann Inst Pasteur (Paris) (1968) 1.44
Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun (1994) 1.44
Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin, and streptolysin O and contains a single cysteine. J Bacteriol (1990) 1.44
Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun (1994) 1.37
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
[Purification of an extracellular thiol-dependent hemolysin from Bacillus alvei]. Biochimie (1977) 1.26
[Preparation and properties of antistreptolysin O horse sera]. Ann Inst Pasteur (Paris) (1965) 1.23
Purification and characterization of Clostridium perfringens delta-toxin. Infect Immun (1981) 1.21
Cytotoxic effects in vitro of highly purified streptolysin O on mouse macrophages cultured in a serum-free medium. J Bacteriol (1966) 1.21
Staphylococcal alpha-toxin: a study of membrane penetration and pore formation. J Biol Chem (1989) 1.20
Purification and some properties of streptolysin O. Biochimie (1973) 1.16
Interaction of alveolysin A sulfhydryl-activated bacterial cytolytic toxin with thiol group reagents and cholesterol. Toxicon (1982) 1.13
The sulfhydryl groups of the thiol-dependent cytolytic toxin from Bacillus alvei evidence for one essential sulfhydryl group. Biochem Biophys Res Commun (1981) 1.11
[Purification of streptolysin O by covalent chromatography on thiol-agarose gel]. C R Acad Sci Hebd Seances Acad Sci D (1978) 1.09
[A simple medium for the production of high titer of streptolysin O. Growth and toxinogenesis on this medium]. Ann Inst Pasteur (Paris) (1965) 1.05
Superantigen bacterial toxins: state of the art. Toxicon (2001) 1.01
Biochemical and ultrastructural study of the disruption of blood platelets by streptolysin O. Biochim Biophys Acta (1979) 1.01
[Antigenic heterogeneity of the M protein of Streptococcus pyogenes type 24]. Ann Inst Pasteur (Paris) (1969) 0.98
Production, purification, and assay of streptolysin S. Methods Enzymol (1988) 0.97
Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome. FEMS Microbiol Lett (1992) 0.96
Production, purification, and assay of streptolysin O. Methods Enzymol (1988) 0.96
Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A. Infect Immun (2001) 0.94
The amphiphilic alpha-helix concept. Consequences on the structure of staphylococcal delta-toxin in solution and bound to lipids. Eur J Biochem (1991) 0.93
Surface properties of bacterial sulfhydryl-activated cytolytic toxins. Interaction with monomolecular films of phosphatidylcholine and various sterols. Eur J Biochem (1984) 0.92
A new kinetic approach for studying phospholipase C (Clostridium perfringens alpha toxin) activity on phospholipid monolayers. Biochemistry (1988) 0.91
Comparative study of biological activities and mitogenic effect of extracts from Haemophilus influenzae type a. Med Microbiol Immunol (1980) 0.91
Photolabeling of staphylococcal alpha-toxin from within rabbit erythrocyte membranes. Biochem Biophys Res Commun (1983) 0.90
Purification of RNA-core induced streptolysin S, and isolation and haemolytic characteristics of the carrier-free toxin. J Gen Microbiol (1986) 0.90
The sulphydryl-activated cytolysin and a sphingomyelinase C are the major membrane-damaging factors involved in cooperative (CAMP-like) haemolysis of Listeria spp. Res Microbiol (1995) 0.90
Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A. Immunol Lett (1982) 0.89
Binding of Clostridium perfringens 125I-labeled delta-toxin to erythrocytes. J Biol Chem (1983) 0.88
Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1. J Immunol (1989) 0.88
Selective cytotoxicity of Clostridium perfringens delta toxin on rabbit leukocytes. Infect Immun (1982) 0.88
Membrane-damaging action of alveolysin from Bacillus alvei. Infect Immun (1981) 0.88
Polyclonal antibody-forming cell activation and immunomodulation of the in vitro immune response induced by streptococcal extracellular products. Cell Immunol (1983) 0.87
Reaction of staphylococcal alpha-toxin with peptide-induced antibodies. Infect Immun (1989) 0.87
Interaction of Clostridium perfringens delta toxin with erythrocyte and liposome membranes and relation with the specific binding to the ganglioside GM2. Toxicon (1989) 0.86
Assay methods for alpha toxin from Clostridium perfringens: phospholipase C. Methods Enzymol (1988) 0.86
Two different modes of membrane damaging action by bacterial thiol-activated haemolysins. Toxicon (1982) 0.86
Ganglioside identification on human monocyte membrane with Clostridium perfringens delta-toxin. J Leukoc Biol (1986) 0.86
Cytokine production by murine cells activated by erythrogenic toxin type A superantigen of Streptococcus pyogenes. Immunobiology (1992) 0.85
Induction of interferon by streptococcus pyogenes extracellular products. Immunol Lett (1982) 0.85
[Purification and some properties of "Clostridium perfringens" delta toxin (author's transl)]. Ann Microbiol (Paris) (1977) 0.85
Damaging effects of Clostridium perfringens delta toxin on blood platelets and their relevance to ganglioside GM2. Arch Biochem Biophys (1988) 0.85
Streptococcal pyrogenic exotoxin A (SPE A) superantigen induced production of hematopoietic cytokines, IL-12 and IL-13 by human peripheral blood mononuclear cells. Microb Pathog (1997) 0.84
Modulation of granulocyte functions by bacterial exotoxin and endotoxins. Immunology (1987) 0.84
Bacterial toxins: an outlook. Toxicon (1982) 0.84
Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections. Zentralbl Bakteriol (1997) 0.83
Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils. Infect Immun (1993) 0.83
Induction of tumour necrosis factor by staphylococcal toxic shock toxin 1. FEMS Microbiol Immunol (1988) 0.83
Modulation of leukotriene generation by pertussis toxin. Infect Immun (1989) 0.82
Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation. Adv Exp Med Biol (1997) 0.82
High production of the acquired immunodeficiency syndrome virus (lymphadenopathy-associated virus) by human T lymphocytes stimulated by streptococcal mitogenic toxins. J Clin Microbiol (1986) 0.82
Purification of alpha toxin from Clostridium perfringens: phospholipase C. Methods Enzymol (1988) 0.81
Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens. Infect Immun (1996) 0.81
A survey of bacterial toxins involved in food poisoning: a suggestion for bacterial food poisoning toxin nomenclature. Int J Food Microbiol (1995) 0.81
Bacterial toxins induce heat shock proteins in human neutrophils. Biochem Biophys Res Commun (1991) 0.81
Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections. Adv Exp Med Biol (1997) 0.81
Growth of Streptococcus pyogenes and streptolysin O production in complex and synthetic media. J Gen Microbiol (1983) 0.81
[Purification and properties of non-specific streptococcal extracellular mitogens]. Ann Immunol (Paris) (1977) 0.80
Species-dependent response to streptococcal lymphocyte mitogens in rabbits, guinea pigs, and mice. Infect Immun (1980) 0.80
One-step purification of the serotonin transporter located at the human platelet plasma membrane. J Biol Chem (1992) 0.79
Characteristics of guinea-pig immune sera elicited by a synthetic diphtheria toxin oligopeptide. Mol Immunol (1982) 0.79
Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever. J Clin Microbiol (1991) 0.79
Effect of staphylococcal delta-toxin and bee venom peptide melittin on leukotriene induction and metabolism of human polymorphonuclear granulocytes. Infect Immun (1990) 0.79
Molecular cloning and characterization of Bacillus alvei thiol-dependent cytolytic toxin expressed in Escherichia coli. J Gen Microbiol (1988) 0.79
Cytokines in streptococcal infections. An opening lecture. Adv Exp Med Biol (1997) 0.78
[Pertussis toxin stimulates brain adenyl cyclase and induces ADP ribosylation of a 40,000 dalton membrane protein]. C R Seances Acad Sci III (1983) 0.78
[Study of the fixation of radio-iodinated streptolysin O on erythrocytes]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.77
Cytokine profile of human peripheral blood mononucleated cells stimulated with a novel streptococcal superantigen, SPEA, SPEC and group A streptococcal cells. Adv Exp Med Biol (1997) 0.77
Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism. Infect Immun (1990) 0.77
Pertussis toxin facilitates the progesterone-induced maturation of Xenopus oocyte. Possible role of protein phosphorylation. FEBS Lett (1985) 0.76
Hypersensitivity reactions in guinea pigs to group A hemolytic streptococci. Int Arch Allergy Appl Immunol (1970) 0.75
[Anti-toxin vaccines]. Ann Inst Pasteur Microbiol (1986) 0.75
The antigenic heterogenity of M protein of Streptococcus pyogenes (type 24). Zentralbl Bakteriol Orig (1970) 0.75
Production, purification, and assay of streptococcal erythrogenic toxin. Methods Enzymol (1988) 0.75
Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts. Med Microbiol Immunol (1984) 0.75
Bifactorial versus monofactorial molecular status of Staphylococcus aureus gamma-toxin. Microb Pathog (1994) 0.75
The phosphoinositide pathway of lymphoid cells: labeling after permeabilization by alveolysin, a bacterial sulfhydryl-activated cytolysin. Eur J Cell Biol (1992) 0.75
Isolation of an (O,H,Vi)-free immunoprotective antigenic fraction with mannose receptor-like activity from Salmonella typhi. J Infect Dis (1981) 0.75
[Quantitative study of anti-streptolysin O activity of human IgG myeloma protein]. Ann Inst Pasteur (Paris) (1970) 0.75
[Assay of human anti-exoproteins to group A streptococci by microhaemagglutination: correlation with anti-streptolysin O and various anti-enzymes (author's transl)]. Ann Microbiol (Paris) (1978) 0.75
Purification of Clostridium perfringens type C theta toxin. Can J Microbiol (1973) 0.75
[Rectovaginal colonization by group B streptococcus]. Presse Med (1983) 0.75
Purified -SH-activated toxins (streptolysin O, alveolysin): new tools for determination of platelet enzyme activities. Thromb Res (1984) 0.75
Solid phase enzyme immunoassays of pertussis toxin using peroxidase or biotin labelled antibodies. J Immunoassay (1987) 0.75
[Experimental delayed streptococcal hypersensitivity in the guinea pig]. Ann Inst Pasteur (Paris) (1969) 0.75
A novel membrane-acting immunotoxin, the immunolysin, with therapeutic potential. Biochem Soc Trans (1992) 0.75